Finance

Lists
PMN:NASDAQ
Promis Neurosciences Inc
၉.၂၁ US$
၀.၀၀%
(၀.၀၀) 1D
၉.၅၃ US$
+၃.၄၇% (+၀.၃၂)
Pre-market
Closed: အောက် ၆, GMT-၄ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PMN...
Mkt. cap
၈.၂၉ ကုဋေ
Avg. vol.
၄.၁၉ သောင်း
Volume
၃၈၉.၀၀
52-wk high
၂၇.၄၀ US$
52-wk low
၆.၂၇ US$
EPS
-၁၂.၆၁ US$
Beta
-၀.၂၃
Shares outstanding
၈.၉၇ သန်း
No. of employees
၁၁
Mkt. cap
၈.၂၉ ကုဋေ
Avg. vol.
၄.၁၉ သောင်း
Volume
၃၈၉.၀၀
52-wk high
၂၇.၄၀ US$
52-wk low
၆.၂၇ US$
EPS
-၁၂.၆၁ US$
Beta
-၀.၂၃
Shares outstanding
၈.၉၇ သန်း
No. of employees
၁၁
News stories
From web sources and news partners
Investing.com Nigeria
Investing.com Nigeria
·
ပြီးခဲ့သည့် ၇ နာရီ
Form 4 ProMIS Neurosciences Inc. For: 7 October By Investing.com
About Promis Neurosciences Inc
CEO-
Employees၁၁
Founded၂၀၀၅
Headquartersမစ်(စ်)ဆွာဂါ, အွန်တေးရီးယိုးပြည်နယ်, ကနေဒါ
Sector-
Analyst ratings
Based on 5 analysts giving stock ratings to PMN in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for PMN in the last 3 months.
Highest
Current ၉.၂၁ US$
၁၀၀.၀၀ US$ (+၉၈၅.၇၈%)
Average
၄၃.၀၀ US$ (+၃၆၆.၈၈%)
Lowest
၁၈.၀၀ US$ (+၉၅.၄၄%)
Analyst
Recommendation
Action
Price target
Projected
Date
Boobalan Pachaiyappan
Roth MKM
Buy
Reiterated
၂၉.၀၀ US$
+၂၁၄.၉%
08/21/2026
Jason McCarthy
Maxim Group
Buy
Maintained
၃၅.၀၀ US$
+၂၈၀%
08/14/2026
Eddie Hickman
Guggenheim
Buy
Reiterated
၁၀၀.၀၀ US$
+၉၈၅.၈%
08/14/2026
Keay Nakae
Chardan Capital
Buy
Maintained
၃၃.၀၀ US$
+၂၅၈.၃%
08/13/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
၁၈.၀၀ US$
+၉၅.၄%
07/15/2026
Unknown Analyst
Guggenheim
Buy
Maintained
၃၅.၀၀ US$
+၂၈၀%
07/14/2026
Pete Stavropoulos
Cantor Fitzgerald
Buy
Initiated
၃၉.၇၅ US$
+၃၃၁.၆%
06/29/2026
Unknown Analyst
Brookline Capital Markets
Buy
Initiated
၄၀.၀၀ US$
+၃၃၄.၃%
05/20/2026
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
၉.၈၀ သန်း
၉.၃၇ သန်း
-
၉.၅၂ သန်း
Cost of revenue
၉.၈၀ သန်း
၉.၃၇ သန်း
-
၉.၅၂ သန်း
Research and development expenses
-
-
၆.၉၇ သန်း
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁.၉၅ သန်း
၁.၄၀ သန်း
၁.၆၇ သန်း
၂.၇၄ သန်း
Operating expense
၁.၉၅ သန်း
၁.၄၀ သန်း
၈.၆၄ သန်း
၂.၇၄ သန်း
Total operating expenses
၁.၁၈ ကုဋေ
၁.၀၈ ကုဋေ
၈.၆၄ သန်း
၁.၂၃ ကုဋေ
Operating income
-၁.၁၈ ကုဋေ
-၁.၀၈ ကုဋေ
-၈.၆၄ သန်း
-၁.၂၃ ကုဋေ
Other non operating income
၁.၇၀ သိန်း
၉.၈၀ သောင်း
၄.၀၁ သိန်း
၅.၃၇ သိန်း
EBT including unusual items
-၁.၁၆ ကုဋေ
-၁.၀၇ ကုဋေ
-၈.၂၄ သန်း
-၁.၁၇ ကုဋေ
EBT excluding unusual items
-၁.၁၆ ကုဋေ
-၁.၀၇ ကုဋေ
-၈.၂၄ သန်း
-၁.၁၇ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၁.၁၆ ကုဋေ
-၁.၀၇ ကုဋေ
-၈.၂၄ သန်း
-၁.၁၇ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ